Correction to: rA1M-035, a Physicochemically Improved Human Recombinant α1-Microglobulin, Has Therapeutic Effects in Rhabdomyolysis-Induced Acute Kidney Injury by Åkerström B, Rosenlöf L, Hägerwall A, Rutardottir S, Ahlstedt J, Johansson ME, Erlandsson L, Allhorn M, and Gram M. Antioxidants & Redox Signaling 30: 489-504, 2019. DOI: 10.1089/ars.2017.7181.

Abstract

Antioxidants & Redox SignalingVol. 32, No. 9 CorrectionsOpen AccessCorrection to: rA1M-035, a Physicochemically Improved Human Recombinant α1-Microglobulin, Has Therapeutic Effects in Rhabdomyolysis-Induced Acute Kidney Injury by Åkerström B, Rosenlöf L, Hägerwall A, Rutardottir S, Ahlstedt J, Johansson ME, Erlandsson L, Allhorn M, and Gram M. Antioxidants & Redox Signaling 30: 489–504, 2019. DOI: 10.1089/ars.2017.7181Published Online:13 Feb 2020https://doi.org/10.1089/ars.2017.7181.correxAboutSectionsPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail In the February 1, 2019 issue of Antioxidants & Redox Signaling (vol. 30, no. 4; 489–504) the article entitled “rA1M-035, a Physicochemically Improved Human Recombinant α1-Microglobulin, Has Therapeutic Effects in Rhabdomyolysis-Induced Acute Kidney Injury” by Åkerström et al. requires correction.The Swedish Foundation for Strategic Research was not listed in the Acknowledgments section as a source of funding for the article.The Acknowledgments section originally read:The authors gratefully acknowledge the invaluable help of Helena Karlsson with animal experiments and Camilla Svanstrӧm with the development and validation of A1M sandwich-ELISA. This work was supported by the Swedish Medical Research Council (VR), governmental ALF research grants to Lund University and Lund University Hospital, the Royal Physiographic Society in Lund, the Foundations of Greta and Johan Kock, Alfred Österlund, Lund University, and the Crafoord Foundation.The Acknowledgments section now reads:The authors gratefully acknowledge the invaluable help of Helena Karlsson with animal experiments and Camilla Svanstrӧm with the development and validation of A1M sandwich-ELISA. This work was supported by the Swedish Medical Research Council (VR), governmental ALF research grants to Lund University and Lund University Hospital, the Royal Physiographic Society in Lund, the Foundations of Greta and Johan Kock, Alfred Österlund, Lund University, the Crafoord Foundation, and the Swedish Foundation for Strategic Research (SSF).The online version has been corrected to reflect this. The authors apologize for this error.FiguresReferencesRelatedDetails Volume 32Issue 9Mar 2020 InformationCopyright 2020, Mary Ann Liebert, Inc., publishersTo cite this article:Correction to: rA1M-035, a Physicochemically Improved Human Recombinant α1-Microglobulin, Has Therapeutic Effects in Rhabdomyolysis-Induced Acute Kidney Injury by Åkerström B, Rosenlöf L, Hägerwall A, Rutardottir S, Ahlstedt J, Johansson ME, Erlandsson L, Allhorn M, and Gram M. Antioxidants & Redox Signaling 30: 489–504, 2019. DOI: 10.1089/ars.2017.7181.Antioxidants & Redox Signaling.Mar 2020.656-656.http://doi.org/10.1089/ars.2017.7181.correxcreative commons licensePublished in Volume: 32 Issue 9: February 13, 2020PDF download